- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.01. | Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| 10.01. | Why Calidi Biotherapeutics (CLDI) Stock Is Down 30% | 1 | Benzinga.com | ||
| 10.01. | Calidi Biotherapeutics slumps 29%, prices $4.25M stock offering | 2 | Seeking Alpha | ||
| CALIDI BIOTHERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 10.01. | Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| 10.01. | Calidi Biotherapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 08.01. | Calidi Biotherapeutics announces proposed public offering | 3 | Seeking Alpha | ||
| 08.01. | Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Proposed Public Offering | 2 | GlobeNewswire (USA) | ||
| 19.12.24 | Calidi Biotherapeutics CEO Allan Camaisa verkauft Aktien im Wert von 16.200 US-Dollar | 3 | Investing.com Deutsch | ||
| 12.12.24 | Calidi Biotherapeutics prices $7.5M secondary offering | 1 | Seeking Alpha | ||
| 12.12.24 | Calidi Biotherapeutics, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 15.11.24 | Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| 14.11.24 | Calidi Biotherapeutics announces pricing of $7.5M public offering of common stock | 2 | Seeking Alpha | ||
| 14.11.24 | Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock | 3 | GlobeNewswire (USA) | ||
| 14.11.24 | Pre-market Movers: California BanCorp, Harrow, Inc., Quantum Computing, BTC Digital, Calidi Biotherapeutics | 944 | AFX News | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.15 A.M. ET).In the Green California BanCorp. (BCAL) is up over 33% at $23.01.
Quantum... ► Artikel lesen | |
| 13.11.24 | Calidi Biotherapeutics plans stock offering | 2 | Investing.com | ||
| 13.11.24 | Calidi Biotherapeutics announces proposed offering | 2 | Seeking Alpha | ||
| 13.11.24 | Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Announces Proposed Public Offering | 5 | GlobeNewswire (USA) | ||
| 13.11.24 | Calidi Biotherapeutics GAAP EPS of -$0.65 | 1 | Seeking Alpha | ||
| 13.11.24 | Calidi Biotherapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.11.24 | Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results | 104 | GlobeNewswire (Europe) | Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma.Presented data supporting RTNova (CLD-400), the company's systemic... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TEMPUS AI | 47,590 | 0,00 % | Tempus AI, Inc. (TEM): Revolutionizing Patient Care with AI-Driven Health Concierge App, Olivia | ||
| QIAGEN | 45,590 | +0,94 % | Biotech Report: Qiagen behauptet, Evotec leichter | (shareribs.com) Frankfurt 20.01.2025 - Die Biotechnologie-Aktien tendierten im deutschen Handel überwiegend schwächer. Die Marktteilnehmer halten sich zurück, da Trump in den USA seine nächste Amtszeit... ► Artikel lesen | |
| IMMUNOVANT | 23,590 | -1,17 % | Immunovant, Inc. (IMVT): The Biotech Stock with Biggest Upside Potential | ||
| SUMMIT THERAPEUTICS | 22,100 | 0,00 % | Why Summit Therapeutics Stock Is Jumping Today | ||
| APOGEE THERAPEUTICS | 39,460 | 0,00 % | Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG333, its Novel Half-Life Extended TSLP Antibody for the Treatment of Respiratory and Broader I&I Conditions | Interim safety and pharmacokinetic data from Phase 1 healthy volunteers trial anticipated in 2H 2025 APG777 + APG333 can potentially address key drivers of respiratory diseases more broadly versus... ► Artikel lesen | |
| VERA THERAPEUTICS | 33,700 | 0,00 % | Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 6,880 | 0,00 % | Recursion Pharmaceuticals, Inc. (RXRX): Revolutionizing Drug Discovery with AI and Strategic Collaborations for Strong Growth | ||
| MODERNA | 34,840 | +0,39 % | Moderna-Aktie heute gut behauptet: Aktienwert steigt (34,8633 €) | Am US-amerikanischen Aktienmarkt notiert der Anteilsschein von Moderna aktuell fester. Der jüngste Kurs betrug 36,27 US-Dollar. Freuen können sich gegenwärtig die Aktionäre von Moderna: Das Wertpapier... ► Artikel lesen | |
| BIONTECH | 112,60 | 0,00 % | Kaufempfehlung bekräftigt: BioNTech: Spannende Pipeline macht Hoffnung auf deutlichen Kursanstieg | © Foto: Julia Cebella - dpaDie Analysten von Berenberg Research sehen großes Potenzial in BioNTechs Onkologie-Pipeline und betonen, dass die bevorstehenden klinischen Auswertungen bis 2025 die Bewertung... ► Artikel lesen | |
| EVOTEC | 7,895 | -0,44 % | Evotec Aktie: Ein Abstieg ist zu befürchten | Die Evotec SE verzeichnet eine bedeutende Veränderung in ihrer Aktionärsstruktur. Der amerikanische Investmentkonzern T. Rowe Price Group hat seine Position am Hamburger Biotech-Unternehmen ausgebaut... ► Artikel lesen | |
| ADMA BIOLOGICS | 16,200 | 0,00 % | EWTX Yields Over 300% Returns, ADMA Records 200% Gains - Did You Strike While The Iron Is Hot? | WASHINGTON (dpa-AFX) - Biotech investing is a high-stakes game that may not suit the faint-hearted due to its inherent volatility. However, this sector can offer astronomical returns when investors... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 40,420 | +3,51 % | Harmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from HC Wainwright | ||
| QUANTUM-SI | 2,440 | 0,00 % | Quantum-Si Incorporated: Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK | Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company, announces its participation in the upcoming Festival of Genomics UK, taking place on... ► Artikel lesen | |
| JANUX THERAPEUTICS | 40,840 | 0,00 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 30,880 | +6,83 % | Royal Bank of Canada Reiterates Outperform Rating for Avidity Biosciences (NASDAQ:RNA) |
CALIDI BIOTHERAPEUTICS INC gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,833 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CALIDI BIOTHERAPEUTICS INC finden Sie auf Wallstreet Online.
